(ACOMO) Amsterdam Commodities - Ratings and Ratios
Spices, Nuts, Dried Fruits, Edible Seeds, Organic Ingredients, Tea, Food
Description: ACOMO Amsterdam Commodities
Acomo N.V. is a global player in the food ingredients industry, leveraging its extensive network and expertise to source, trade, process, and distribute a diverse range of products, including spices, nuts, edible seeds, organic ingredients, tea, and food solutions, to major food and beverage companies worldwide.
The companys diversified portfolio is segmented into five key areas: Spices and Nuts, Edible Seeds, Organic Ingredients, Tea, and Food Solutions, allowing it to capitalize on various market trends and opportunities, such as the growing demand for organic and specialty products, as well as the increasing popularity of plant-based solutions.
With a rich history dating back to 1908, Acomo N.V. has established itself as a trusted partner in the industry, providing high-quality products and services, including product development, manufacturing, packaging, and inventory management, to its customers, who include major food companies and retailers.
Analyzing the companys
Based on the analysis, our forecast suggests that Acomo N.V.s stock is likely to continue its upward trend, driven by the companys strong market position, diversified portfolio, and growing demand for its products. We expect the stock to reach €25.00 in the next 6-12 months, representing a potential upside of 10.4% from the current price. However, its essential to monitor the companys future performance and adjust our forecast accordingly.
ACOMO Stock Overview
Market Cap in USD | 784m |
Sub-Industry | Food Distributors |
IPO / Inception |
ACOMO Stock Ratings
Growth Rating | 50.8% |
Fundamental | 76.8% |
Dividend Rating | 53.1% |
Return 12m vs S&P 500 | 17.3% |
Analyst Rating | - |
ACOMO Dividends
Dividend Yield 12m | 6.23% |
Yield on Cost 5y | 8.54% |
Annual Growth 5y | 0.89% |
Payout Consistency | 82.5% |
Payout Ratio | 55.6% |
ACOMO Growth Ratios
Growth Correlation 3m | 5.5% |
Growth Correlation 12m | 91.3% |
Growth Correlation 5y | 6.6% |
CAGR 5y | 8.46% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | -0.20 |
Alpha | 0.05 |
Beta | 0.703 |
Volatility | 16.58% |
Current Volume | 32.5k |
Average Volume 20d | 17.9k |
Stop Loss | 22.3 (-3%) |
Signal | 2.18 |
Piotroski VR‑10 (Strict, 0-10) 7.0
Net Income (63.3m TTM) > 0 and > 6% of Revenue (6% = 118.6m TTM) |
FCFTA 0.24 (>2.0%) and ΔFCFTA 8.37pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 14.87% (prev 20.79%; Δ -5.92pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.29 (>3.0%) and CFO 255.1m > Net Income 63.3m (YES >=105%, WARN >=100%) |
Net Debt (223.4m) to EBITDA (157.4m) ratio: 1.42 <= 3.0 (WARN <= 3.5) |
Current Ratio 2.02 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (29.6m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
Gross Margin 13.45% (prev 13.55%; Δ -0.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 228.7% (prev 156.4%; Δ 72.34pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 5.33 (EBITDA TTM 157.4m / Interest Expense TTM 24.0m) >= 6 (WARN >= 3) |
Altman Z'' 4.54
(A) 0.34 = (Total Current Assets 581.7m - Total Current Liabilities 287.7m) / Total Assets 867.9m |
(B) 0.25 = Retained Earnings (Balance) 212.7m / Total Assets 867.9m |
(C) 0.15 = EBIT TTM 128.0m / Avg Total Assets 864.3m |
(D) 0.50 = Book Value of Equity 212.7m / Total Liabilities 428.2m |
Total Rating: 4.54 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 76.83
1. Piotroski 7.0pt = 2.0 |
2. FCF Yield 22.82% = 5.0 |
3. FCF Margin 10.34% = 2.58 |
4. Debt/Equity 0.52 = 2.37 |
5. Debt/Ebitda 1.45 = 1.04 |
6. ROIC - WACC 6.96% = 8.70 |
7. RoE 15.27% = 1.27 |
8. Rev. Trend 65.85% = 3.29 |
9. Rev. CAGR 0.0% = 0.0 |
10. EPS Trend 23.02% = 0.58 |
11. EPS CAGR 0.0% = 0.0 |
What is the price of ACOMO shares?
Over the past week, the price has changed by +4.07%, over one month by +4.07%, over three months by +1.99% and over the past year by +39.96%.
Is Amsterdam Commodities a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ACOMO is around 23.66 EUR . This means that ACOMO is currently overvalued and has a potential downside of 2.87%.
Is ACOMO a buy, sell or hold?
What are the forecasts/targets for the ACOMO price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 26 | 13% |
Analysts Target Price | - | - |
ValueRay Target Price | 26.1 | 13.3% |
ACOMO Fundamental Data Overview
Market Cap EUR = 672.5m (672.5m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = 5.63m EUR (Cash only, last quarter)
P/E Trailing = 9.6795
P/E Forward = 10.3734
P/S = 0.4628
P/B = 1.601
Beta = 0.448
Revenue TTM = 1.98b EUR
EBIT TTM = 128.0m EUR
EBITDA TTM = 157.4m EUR
Long Term Debt = 110.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 118.8m EUR (from shortLongTermDebt, last quarter)
Debt = 229.0m EUR (Calculated: Short Term 118.8m + Long Term 110.2m)
Net Debt = 223.4m EUR (from netDebt column, last quarter)
Enterprise Value = 895.9m EUR (672.5m + Debt 229.0m - CCE 5.63m)
Interest Coverage Ratio = 5.33 (Ebit TTM 128.0m / Interest Expense TTM 24.0m)
FCF Yield = 22.82% (FCF TTM 204.4m / Enterprise Value 895.9m)
FCF Margin = 10.34% (FCF TTM 204.4m / Revenue TTM 1.98b)
Net Margin = 3.20% (Net Income TTM 63.3m / Revenue TTM 1.98b)
Gross Margin = 13.45% ((Revenue TTM 1.98b - Cost of Revenue TTM 1.71b) / Revenue TTM)
Tobins Q-Ratio = 4.21 (Enterprise Value 895.9m / Book Value Of Equity 212.7m)
Interest Expense / Debt = 3.91% (Interest Expense 8.96m / Debt 229.0m)
Taxrate = 29.19% (7.28m / 24.9m)
NOPAT = 90.7m (EBIT 128.0m * (1 - 29.19%))
Current Ratio = 2.02 (Total Current Assets 581.7m / Total Current Liabilities 287.7m)
Debt / Equity = 0.52 (Debt 229.0m / last Quarter total Stockholder Equity 438.1m)
Debt / EBITDA = 1.45 (Net Debt 223.4m / EBITDA 157.4m)
Debt / FCF = 1.12 (Debt 229.0m / FCF TTM 204.4m)
Total Stockholder Equity = 414.4m (last 4 quarters mean)
RoA = 7.29% (Net Income 63.3m, Total Assets 867.9m )
RoE = 15.27% (Net Income TTM 63.3m / Total Stockholder Equity 414.4m)
RoCE = 24.41% (Ebit 128.0m / (Equity 414.4m + L.T.Debt 110.2m))
RoIC = 14.08% (NOPAT 90.7m / Invested Capital 644.2m)
WACC = 7.12% (E(672.5m)/V(901.5m) * Re(8.60%)) + (D(229.0m)/V(901.5m) * Rd(3.91%) * (1-Tc(0.29)))
Shares Correlation 5-Years: 97.50 | Cagr: 4.70%
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 79.66% ; FCFE base≈174.9m ; Y1≈215.8m ; Y5≈368.2m
Fair Price DCF = 190.0 (DCF Value 5.63b / Shares Outstanding 29.6m; 5y FCF grow 25.0% → 3.0% )
Revenue Correlation: 65.85 | Revenue CAGR: 0.0%
Rev Growth-of-Growth: -90.95
EPS Correlation: 23.02 | EPS CAGR: 0.0%
EPS Growth-of-Growth: 372.2